MovDisordV3, PascalFrancis, Corpus, bibRecord, 003313

Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment

Identifieur interne : 003313 ( PascalFrancis/Corpus ); précédent : 003312; suivant : 003314

Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment

Auteurs : A. Benazzouz ; T. Boraud ; J. Feger ; P. Burbaud ; B. Bioulac ; C. Gross

Source :

Movement disorders [ 0885-3185 ] ; 1996.

RBID : Pascal:97-0015779

Descripteurs français

Pascal (Inist)
- Parkinsonisme, Unilatéral, Stimulation instrumentale, Haute fréquence, Electrique, Noyau sousthalamique, Hypertonie spastique, Akinésie, Etude expérimentale, Traitement, Animal, Primates, Etude comparative, Dopa, Antiparkinsonien, Aminoacide.

English descriptors

KwdEn :
- Akinesia, Aminoacid, Animal, Antiparkinson agent, Comparative study, Dopa, Electric, Experimental study, High frequency, Instrumental stimulation, Parkinsonism, Primates, Spasticity, Subthalamic nucleus, Treatment, Unilateral.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 11`
A06				`@2 6`
A08	`01`	`1`	`ENG`	`@1 Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment`
A11	`01`	`1`		`@1 BENAZZOUZ (A.)`
A11	`02`	`1`		`@1 BORAUD (T.)`
A11	`03`	`1`		`@1 FEGER (J.)`
A11	`04`	`1`		`@1 BURBAUD (P.)`
A11	`05`	`1`		`@1 BIOULAC (B.)`
A11	`06`	`1`		`@1 GROSS (C.)`
A14	`01`			`@1 Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II @2 Bordeaux @3 FRA @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut.`
A14	`02`			`@1 Laboratoire de Pharmacologie, Université R. Descartes @2 Paris @3 FRA @Z 3 aut.`
A20				`@1 627-632`
A21				`@1 1996`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000066890620030`
A44				`@0 0000 @1 © 1997 INIST-CNRS. All rights reserved.`
A45				`@0 21 ref.`
A47	`01`	`1`		`@0 97-0015779`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinsonisme @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinsonism @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson síndrome @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Unilatéral @5 02`
C03	`02`	`X`	`ENG`	`@0 Unilateral @5 02`
C03	`02`	`X`	`SPA`	`@0 Unilateral @5 02`
C03	`03`	`X`	`FRE`	`@0 Stimulation instrumentale @5 04`
C03	`03`	`X`	`ENG`	`@0 Instrumental stimulation @5 04`
C03	`03`	`X`	`SPA`	`@0 Estimulación instrumental @5 04`
C03	`04`	`X`	`FRE`	`@0 Haute fréquence @5 05`
C03	`04`	`X`	`ENG`	`@0 High frequency @5 05`
C03	`04`	`X`	`GER`	`@0 Hochfrequenz @5 05`
C03	`04`	`X`	`SPA`	`@0 Alta frecuencia @5 05`
C03	`05`	`X`	`FRE`	`@0 Electrique @5 06`
C03	`05`	`X`	`ENG`	`@0 Electric @5 06`
C03	`05`	`X`	`SPA`	`@0 Eléctrico @5 06`
C03	`06`	`X`	`FRE`	`@0 Noyau sousthalamique @5 07`
C03	`06`	`X`	`ENG`	`@0 Subthalamic nucleus @5 07`
C03	`06`	`X`	`SPA`	`@0 Núcleo subtalámico @5 07`
C03	`07`	`X`	`FRE`	`@0 Hypertonie spastique @5 10`
C03	`07`	`X`	`ENG`	`@0 Spasticity @5 10`
C03	`07`	`X`	`SPA`	`@0 Hipertonia espástica @5 10`
C03	`08`	`X`	`FRE`	`@0 Akinésie @5 13`
C03	`08`	`X`	`ENG`	`@0 Akinesia @5 13`
C03	`08`	`X`	`SPA`	`@0 Aquinesia @5 13`
C03	`09`	`X`	`FRE`	`@0 Etude expérimentale @5 16`
C03	`09`	`X`	`ENG`	`@0 Experimental study @5 16`
C03	`09`	`X`	`GER`	`@0 Experimentelle Untersuchung @5 16`
C03	`09`	`X`	`SPA`	`@0 Estudio experimental @5 16`
C03	`10`	`X`	`FRE`	`@0 Traitement @5 17`
C03	`10`	`X`	`ENG`	`@0 Treatment @5 17`
C03	`10`	`X`	`GER`	`@0 Aufbereiten @5 17`
C03	`10`	`X`	`SPA`	`@0 Tratamiento @5 17`
C03	`11`	`X`	`FRE`	`@0 Animal @5 20`
C03	`11`	`X`	`ENG`	`@0 Animal @5 20`
C03	`11`	`X`	`SPA`	`@0 Animal @5 20`
C03	`12`	`X`	`FRE`	`@0 Primates @2 NS @5 21`
C03	`12`	`X`	`ENG`	`@0 Primates @2 NS @5 21`
C03	`12`	`X`	`SPA`	`@0 Primates @2 NS @5 21`
C03	`13`	`X`	`FRE`	`@0 Etude comparative @5 23`
C03	`13`	`X`	`ENG`	`@0 Comparative study @5 23`
C03	`13`	`X`	`GER`	`@0 Vergleich @5 23`
C03	`13`	`X`	`SPA`	`@0 Estudio comparativo @5 23`
C03	`14`	`X`	`FRE`	`@0 Dopa @2 NK @2 FR @5 24`
C03	`14`	`X`	`ENG`	`@0 Dopa @2 NK @2 FR @5 24`
C03	`14`	`X`	`SPA`	`@0 Dopa @2 NK @2 FR @5 24`
C03	`15`	`X`	`FRE`	`@0 Antiparkinsonien @5 35`
C03	`15`	`X`	`ENG`	`@0 Antiparkinson agent @5 35`
C03	`15`	`X`	`SPA`	`@0 Antiparkinsoniano @5 35`
C03	`16`	`X`	`FRE`	`@0 Aminoacide @5 36`
C03	`16`	`X`	`ENG`	`@0 Aminoacid @5 36`
C03	`16`	`X`	`SPA`	`@0 Aminoácido @5 36`
C07	`01`	`X`	`FRE`	`@0 Mammalia @2 NS`
C07	`01`	`X`	`ENG`	`@0 Mammalia @2 NS`
C07	`01`	`X`	`SPA`	`@0 Mammalia @2 NS`
C07	`02`	`X`	`FRE`	`@0 Vertebrata @2 NS`
C07	`02`	`X`	`ENG`	`@0 Vertebrata @2 NS`
C07	`02`	`X`	`SPA`	`@0 Vertebrata @2 NS`
C07	`03`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`05`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`05`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`05`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`06`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`06`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`06`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`07`	`X`	`FRE`	`@0 Traitement instrumental @5 45`
C07	`07`	`X`	`ENG`	`@0 Instrumentation therapy @5 45`
C07	`07`	`X`	`SPA`	`@0 Tratamiento instrumental @5 45`
C07	`08`	`X`	`FRE`	`@0 Muscle strié pathologie @5 61`
C07	`08`	`X`	`ENG`	`@0 Striated muscle disease @5 61`
C07	`08`	`X`	`SPA`	`@0 Músculo estriado patología @5 61`
C07	`09`	`X`	`FRE`	`@0 Trouble tonus @5 62`
C07	`09`	`X`	`ENG`	`@0 Muscle tonus alteration @5 62`
C07	`09`	`X`	`SPA`	`@0 Trastorno tono muscular @5 62`
C07	`10`	`X`	`FRE`	`@0 Trouble neurologique @5 64`
C07	`10`	`X`	`ENG`	`@0 Neurological disorder @5 64`
C07	`10`	`X`	`SPA`	`@0 Trastorno neurológico @5 64`
C07	`11`	`X`	`FRE`	`@0 Trouble moteur @5 73`
C07	`11`	`X`	`ENG`	`@0 Motor system disorder @5 73`
C07	`11`	`X`	`SPA`	`@0 Trastorno motor @5 73`
N21				`@1 006`

Format Inist (serveur)

NO :	PASCAL 97-0015779 INIST
ET :	Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment
AU :	BENAZZOUZ (A.); BORAUD (T.); FEGER (J.); BURBAUD (P.); BIOULAC (B.); GROSS (C.)
AF :	Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II/Bordeaux/France (1 aut., 2 aut., 4 aut., 5 aut., 6 aut.); Laboratoire de Pharmacologie, Université R. Descartes/Paris/France (3 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 6; Pp. 627-632; Bibl. 21 ref.
LA :	Anglais
CC :	002B17G
FD :	Parkinsonisme; Unilatéral; Stimulation instrumentale; Haute fréquence; Electrique; Noyau sousthalamique; Hypertonie spastique; Akinésie; Etude expérimentale; Traitement; Animal; Primates; Etude comparative; Dopa; Antiparkinsonien; Aminoacide
FG :	Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Traitement instrumental; Muscle strié pathologie; Trouble tonus; Trouble neurologique; Trouble moteur
ED :	Parkinsonism; Unilateral; Instrumental stimulation; High frequency; Electric; Subthalamic nucleus; Spasticity; Akinesia; Experimental study; Treatment; Animal; Primates; Comparative study; Dopa; Antiparkinson agent; Aminoacid
EG :	Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Instrumentation therapy; Striated muscle disease; Muscle tonus alteration; Neurological disorder; Motor system disorder
GD :	Hochfrequenz; Experimentelle Untersuchung; Aufbereiten; Vergleich
SD :	Parkinson síndrome; Unilateral; Estimulación instrumental; Alta frecuencia; Eléctrico; Núcleo subtalámico; Hipertonia espástica; Aquinesia; Estudio experimental; Tratamiento; Animal; Primates; Estudio comparativo; Dopa; Antiparkinsoniano; Aminoácido
LO :	INIST-20953.354000066890620030
ID :	97-0015779

Links to Exploration step

Pascal:97-0015779

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment</title>
<author><name sortKey="Benazzouz, A" sort="Benazzouz, A" uniqKey="Benazzouz A" first="A." last="Benazzouz">A. Benazzouz</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Boraud, T" sort="Boraud, T" uniqKey="Boraud T" first="T." last="Boraud">T. Boraud</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Feger, J" sort="Feger, J" uniqKey="Feger J" first="J." last="Feger">J. Feger</name>
<affiliation><inist:fA14 i1="02"><s1>Laboratoire de Pharmacologie, Université R. Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Burbaud, P" sort="Burbaud, P" uniqKey="Burbaud P" first="P." last="Burbaud">P. Burbaud</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bioulac, B" sort="Bioulac, B" uniqKey="Bioulac B" first="B." last="Bioulac">B. Bioulac</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gross, C" sort="Gross, C" uniqKey="Gross C" first="C." last="Gross">C. Gross</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">97-0015779</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 97-0015779 INIST</idno>
<idno type="RBID">Pascal:97-0015779</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003313</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment</title>
<author><name sortKey="Benazzouz, A" sort="Benazzouz, A" uniqKey="Benazzouz A" first="A." last="Benazzouz">A. Benazzouz</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Boraud, T" sort="Boraud, T" uniqKey="Boraud T" first="T." last="Boraud">T. Boraud</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Feger, J" sort="Feger, J" uniqKey="Feger J" first="J." last="Feger">J. Feger</name>
<affiliation><inist:fA14 i1="02"><s1>Laboratoire de Pharmacologie, Université R. Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Burbaud, P" sort="Burbaud, P" uniqKey="Burbaud P" first="P." last="Burbaud">P. Burbaud</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bioulac, B" sort="Bioulac, B" uniqKey="Bioulac B" first="B." last="Bioulac">B. Bioulac</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gross, C" sort="Gross, C" uniqKey="Gross C" first="C." last="Gross">C. Gross</name>
<affiliation><inist:fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Akinesia</term>
<term>Aminoacid</term>
<term>Animal</term>
<term>Antiparkinson agent</term>
<term>Comparative study</term>
<term>Dopa</term>
<term>Electric</term>
<term>Experimental study</term>
<term>High frequency</term>
<term>Instrumental stimulation</term>
<term>Parkinsonism</term>
<term>Primates</term>
<term>Spasticity</term>
<term>Subthalamic nucleus</term>
<term>Treatment</term>
<term>Unilateral</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinsonisme</term>
<term>Unilatéral</term>
<term>Stimulation instrumentale</term>
<term>Haute fréquence</term>
<term>Electrique</term>
<term>Noyau sousthalamique</term>
<term>Hypertonie spastique</term>
<term>Akinésie</term>
<term>Etude expérimentale</term>
<term>Traitement</term>
<term>Animal</term>
<term>Primates</term>
<term>Etude comparative</term>
<term>Dopa</term>
<term>Antiparkinsonien</term>
<term>Aminoacide</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>11</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>BENAZZOUZ (A.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>BORAUD (T.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>FEGER (J.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>BURBAUD (P.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BIOULAC (B.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>GROSS (C.)</s1>
</fA11>
<fA14 i1="01"><s1>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Laboratoire de Pharmacologie, Université R. Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>627-632</s1>
</fA20>
<fA21><s1>1996</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000066890620030</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>21 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>97-0015779</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinsonisme</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinsonism</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson síndrome</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Unilatéral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Unilateral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Unilateral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Stimulation instrumentale</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Instrumental stimulation</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Estimulación instrumental</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Haute fréquence</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>High frequency</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="GER"><s0>Hochfrequenz</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Alta frecuencia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Electrique</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Electric</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Eléctrico</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Noyau sousthalamique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Subthalamic nucleus</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Núcleo subtalámico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Hypertonie spastique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Spasticity</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hipertonia espástica</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Akinésie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Akinesia</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Aquinesia</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etude expérimentale</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Experimental study</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="GER"><s0>Experimentelle Untersuchung</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estudio experimental</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Primates</s0>
<s2>NS</s2>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Primates</s0>
<s2>NS</s2>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Primates</s0>
<s2>NS</s2>
<s5>21</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>23</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>23</s5>
</fC03>
<fC03 i1="13" i2="X" l="GER"><s0>Vergleich</s0>
<s5>23</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>23</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>24</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>24</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>24</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
<s5>35</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
<s5>35</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
<s5>35</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Aminoacide</s0>
<s5>36</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Aminoacid</s0>
<s5>36</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Aminoácido</s0>
<s5>36</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Traitement instrumental</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Instrumentation therapy</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Tratamiento instrumental</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Muscle strié pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Striated muscle disease</s0>
<s5>61</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Músculo estriado patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Trouble tonus</s0>
<s5>62</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Muscle tonus alteration</s0>
<s5>62</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Trastorno tono muscular</s0>
<s5>62</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>64</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>64</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>64</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE"><s0>Trouble moteur</s0>
<s5>73</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG"><s0>Motor system disorder</s0>
<s5>73</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA"><s0>Trastorno motor</s0>
<s5>73</s5>
</fC07>
<fN21><s1>006</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 97-0015779 INIST</NO>
<ET>Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment</ET>
<AU>BENAZZOUZ (A.); BORAUD (T.); FEGER (J.); BURBAUD (P.); BIOULAC (B.); GROSS (C.)</AU>
<AF>Laboratoire de Neurophysiologie, CNRS URA 1200, Université de Bordeaux II/Bordeaux/France (1 aut., 2 aut., 4 aut., 5 aut., 6 aut.); Laboratoire de Pharmacologie, Université R. Descartes/Paris/France (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1996; Vol. 11; No. 6; Pp. 627-632; Bibl. 21 ref.</SO>
<LA>Anglais</LA>
<CC>002B17G</CC>
<FD>Parkinsonisme; Unilatéral; Stimulation instrumentale; Haute fréquence; Electrique; Noyau sousthalamique; Hypertonie spastique; Akinésie; Etude expérimentale; Traitement; Animal; Primates; Etude comparative; Dopa; Antiparkinsonien; Aminoacide</FD>
<FG>Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Traitement instrumental; Muscle strié pathologie; Trouble tonus; Trouble neurologique; Trouble moteur</FG>
<ED>Parkinsonism; Unilateral; Instrumental stimulation; High frequency; Electric; Subthalamic nucleus; Spasticity; Akinesia; Experimental study; Treatment; Animal; Primates; Comparative study; Dopa; Antiparkinson agent; Aminoacid</ED>
<EG>Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Instrumentation therapy; Striated muscle disease; Muscle tonus alteration; Neurological disorder; Motor system disorder</EG>
<GD>Hochfrequenz; Experimentelle Untersuchung; Aufbereiten; Vergleich</GD>
<SD>Parkinson síndrome; Unilateral; Estimulación instrumental; Alta frecuencia; Eléctrico; Núcleo subtalámico; Hipertonia espástica; Aquinesia; Estudio experimental; Tratamiento; Animal; Primates; Estudio comparativo; Dopa; Antiparkinsoniano; Aminoácido</SD>
<LO>INIST-20953.354000066890620030</LO>
<ID>97-0015779</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003313 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003313 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:97-0015779
   |texte=   Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment

Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment

Source :

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri